Usefulness of serum tryptase level as an independent biomarker for coronary plaque instability in a Chinese population.
about
Emerging role of mast cells and macrophages in cardiovascular and metabolic diseasesMast cells as effectors in atherosclerosisCirculating tryptase as a marker for subclinical atherosclerosis in obese subjects.Immunoglobulin E and mast cell proteases are potential risk factors of human pre-diabetes and diabetes mellitus.Identification of sites in apolipoprotein A-I susceptible to chymase and carboxypeptidase A digestion.Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases.Association between SNP rs1800875, serum chymase and immunoglobulin E levels in patients with coronary heart diseaseElevated Serum Tryptase and Endothelin in Patients with ST Segment Elevation Myocardial Infarction: Preliminary ReportAnalysis of Inflammatory Mediators in Prediabetes and Newly Diagnosed Type 2 Diabetes PatientsMast cells and acute coronary syndromes: relationship between serum tryptase, clinical outcome and severity of coronary artery diseaseMast cell chymase and tryptase as targets for cardiovascular and metabolic diseases.Immunoglobulin E and mast cell proteases are potential risk factors of impaired fasting glucose and impaired glucose tolerance in humans.Kounis syndrome: a new twist on an old disease.Mast cells in human carotid atherosclerotic plaques are associated with intraplaque microvessel density and the occurrence of future cardiovascular events.Serum tryptase detected during acute coronary syndrome is significantly related to the development of major adverse cardiovascular events after 2 years.Dynamic changes and clinical significance of serum tryptase levels in STEMI patients treated with primary PCI.Increased level of soluble syndecan-1 in serum correlates with myocardial expression in a rat model of myocardial infarction.
P2860
Q26825467-13F00338-3271-4443-AB27-1B542FF90FEAQ26995160-C9958F07-ECEC-41C9-95FC-5E70F1EF28CCQ33618430-2F1C6427-508B-4DB8-B33E-82CCBEF2D177Q34110586-EF5C55ED-BFCA-41A0-A29E-2DB78133C845Q34448664-B036EBF8-E342-49B2-80E4-D4E83F965034Q35098737-B9143E7C-FA83-454A-BB3F-4B338877AA40Q35148852-9DBBBFD3-686D-44E1-9AE8-B7426E3538DCQ35674011-14B973C7-E505-4C18-B4F9-2CCDDB1AE7C4Q37104776-AD50FEF0-280E-454E-B0B7-1D796DF8B383Q37312777-C7C39A7B-C441-4B83-ACFE-F33B79C7CDAEQ37578873-9E7A9985-0093-42FA-AF40-03E8E4FCA948Q37602518-0739E558-7827-4D4F-9767-A808356C9E6BQ37952253-C5168551-4361-4D4D-ADBF-0B634EAB0881Q39404175-26F097A6-16E7-43C3-85CB-9FE4B5C9CE9CQ41541775-D852879A-71C0-40D2-9B27-DD5E56E8BE04Q45717628-3BA8AD17-B35E-4CBB-ABAB-D64E79962BDFQ54353984-60197745-7A54-46D4-9483-CD7620F05EF1
P2860
Usefulness of serum tryptase level as an independent biomarker for coronary plaque instability in a Chinese population.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Usefulness of serum tryptase l ...... ility in a Chinese population.
@ast
Usefulness of serum tryptase l ...... ility in a Chinese population.
@en
Usefulness of serum tryptase l ...... ility in a Chinese population.
@nl
type
label
Usefulness of serum tryptase l ...... ility in a Chinese population.
@ast
Usefulness of serum tryptase l ...... ility in a Chinese population.
@en
Usefulness of serum tryptase l ...... ility in a Chinese population.
@nl
prefLabel
Usefulness of serum tryptase l ...... ility in a Chinese population.
@ast
Usefulness of serum tryptase l ...... ility in a Chinese population.
@en
Usefulness of serum tryptase l ...... ility in a Chinese population.
@nl
P2093
P2860
P1433
P1476
Usefulness of serum tryptase l ...... ility in a Chinese population.
@en
P2093
Guo-Ping Shi
Jianan Wang
Jiusong Sun
Meixiang Xiang
P2860
P304
P356
10.1016/J.ATHEROSCLEROSIS.2011.01.006
P577
2011-01-26T00:00:00Z